China Resources Pharmaceutical (03320): Tianshili Pharmaceutical's net profit for the first half of the year was 893 million yuan, an increase of 15.23% over the previous year

Zhitongcaijing · 3d ago

Zhitong Finance App News, China Resources Pharmaceutical (03320) announced that in the first half of 2026, Tianshili Pharmaceutical achieved total operating revenue of RMB 4.201 billion (down 2.03% year on year, mainly due to the overall decline in the Chinese medicine injection industry and a decrease in sales revenue from cold and fever drugs compared to the same period last year), and shareholders of listed companies should account for a net profit of RMB 893 million, an increase of 15.23% year on year; shareholders of listed companies should account for net profit of RMB 881 million (excluding non-recurring profit and loss) of RMB 36.01% year on year.